Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 11Recruiting 3Not yet recruiting 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1CNS 1

Conditions

Ovarian Neoplasms 1Glioma 1Frailty 1Endometrial Neoplasms 1Caregiving for Cancer 1Brain Neoplasms 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Psychosocial Intervention × Clear all
NCT04789694 2026-03-19

PHOCUS

Charles University, Czech Republic

Phase 3 Recruiting
64 enrolled
Gynecologic

Frailty, Ovarian Neoplasms, Endometrial Neoplasms

NCT07139769 2025-12-05

RAISE

Massachusetts General Hospital

Phase NA Recruiting
48 enrolled

Caregiving for Cancer

NCT06099743 2025-07-14

ASCENT Intervention for Brain Tumor Patients

Massachusetts General Hospital

Phase NA Recruiting
100 enrolled
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡